Independent Research Analysts Give Carl Zeiss Meditec (AFX) a €54.00 Price Target

Independent Research set a €54.00 ($64.29) target price on Carl Zeiss Meditec (ETR:AFX) in a research note issued to investors on Friday, December 8th. The firm currently has a neutral rating on the stock.

Other equities analysts also recently issued reports about the stock. Berenberg Bank set a €48.00 ($57.14) price target on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research note on Tuesday, October 17th. DZ Bank reiterated a sell rating on shares of Carl Zeiss Meditec in a research report on Thursday, October 19th. Deutsche Bank set a €40.00 ($47.62) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a report on Friday, December 1st. Commerzbank set a €42.00 ($50.00) target price on Carl Zeiss Meditec and gave the stock a neutral rating in a report on Friday, December 8th. Finally, set a €52.00 ($61.90) target price on Carl Zeiss Meditec and gave the stock a buy rating in a report on Friday, November 10th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of Hold and an average price target of €50.36 ($59.95).

Carl Zeiss Meditec (ETR AFX) traded down €0.36 ($0.43) during midday trading on Friday, reaching €51.40 ($61.19). 54,435 shares of the company’s stock were exchanged, compared to its average volume of 91,142. Carl Zeiss Meditec has a 1-year low of €33.62 ($40.02) and a 1-year high of €53.35 ($63.51). The stock has a market cap of $4,630.00 and a P/E ratio of 32.74.

WARNING: “Independent Research Analysts Give Carl Zeiss Meditec (AFX) a €54.00 Price Target” was originally posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this piece on another domain, it was stolen and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.truebluetribune.com/2018/01/02/independent-research-analysts-give-carl-zeiss-meditec-afx-a-54-00-price-target.html.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply